PDCD1 and neoplasm: Similar to the combination treatment of CGP57380 and an anti–PD-1 antibody (Figures 3 and 4), the combination of CGP57380 and anti–CSF-1R antibody significantly prolonged the overall survival of tumor-bearing mice (Figure 8E).